Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter].

Phillip M, Achenbach P, Addala A, Albanese-O'Neill A, Battelino T, Bell KJ, Besser REJ, Bonifacio E, Colhoun HM, Couper JJ, Craig ME, Danne T, de Beaufort C, Dovc K, Dutta S, Ebekozien O, Elding Larsson H, Frohnert BI, Gallagher MP, Greenbaum CJ, Griffin KJ, Hagopian W, Haller MJ, Hendriks E, Holt RIG, Ismail HM, Jacobsen LM, Kolb LE, Kordonouri O, Lange K, Lash RW, Lernmark Å, Libman I, Lundgren M, Maahs DM, Marcovecchio ML, Mathieu C, Oron T, Patil SP, Rewers MJ, Rich SS, Schatz DA, Schulman-Rosenbaum R, Simmons KM, Sims EK, Skyler JS, Speake C, Steck AK, Tonyushkina KN, Veijola R, Wentworth JM, Wherrett DK, Wood JR, Ziegler AG, DiMeglio LA

Open source

DOI: 10.1007/s00125-024-06350-x
Published: 2025 Apr
Container: Diabetologia
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00125-024-06350-x,
  title = {Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter].},
  author = {Phillip M and Achenbach P and Addala A and Albanese-O'Neill A and Battelino T and Bell KJ and Besser REJ and Bonifacio E and Colhoun HM and Couper JJ and Craig ME and Danne T and de Beaufort C and Dovc K and Dutta S and Ebekozien O and Elding Larsson H and Frohnert BI and Gallagher MP and Greenbaum CJ and Griffin KJ and Hagopian W and Haller MJ and Hendriks E and Holt RIG and Ismail HM and Jacobsen LM and Kolb LE and Kordonouri O and Lange K and Lash RW and Lernmark Å and Libman I and Lundgren M and Maahs DM and Marcovecchio ML and Mathieu C and Oron T and Patil SP and Rewers MJ and Rich SS and Schatz DA and Schulman-Rosenbaum R and Simmons KM and Sims EK and Skyler JS and Speake C and Steck AK and Tonyushkina KN and Veijola R and Wentworth JM and Wherrett DK and Wood JR and Ziegler AG and DiMeglio LA},
  year = {2025},
  journal = {Diabetologia},
  doi = {10.1007/s00125-024-06350-x},
  url = {https://doi.org/10.1007/s00125-024-06350-x}
}

RIS

TY  - JOUR
TI  - Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter].
AU  - Phillip M
AU  - Achenbach P
AU  - Addala A
AU  - Albanese-O'Neill A
AU  - Battelino T
AU  - Bell KJ
AU  - Besser REJ
AU  - Bonifacio E
AU  - Colhoun HM
AU  - Couper JJ
AU  - Craig ME
AU  - Danne T
AU  - de Beaufort C
AU  - Dovc K
AU  - Dutta S
AU  - Ebekozien O
AU  - Elding Larsson H
AU  - Frohnert BI
AU  - Gallagher MP
AU  - Greenbaum CJ
AU  - Griffin KJ
AU  - Hagopian W
AU  - Haller MJ
AU  - Hendriks E
AU  - Holt RIG
AU  - Ismail HM
AU  - Jacobsen LM
AU  - Kolb LE
AU  - Kordonouri O
AU  - Lange K
AU  - Lash RW
AU  - Lernmark Å
AU  - Libman I
AU  - Lundgren M
AU  - Maahs DM
AU  - Marcovecchio ML
AU  - Mathieu C
AU  - Oron T
AU  - Patil SP
AU  - Rewers MJ
AU  - Rich SS
AU  - Schatz DA
AU  - Schulman-Rosenbaum R
AU  - Simmons KM
AU  - Sims EK
AU  - Skyler JS
AU  - Speake C
AU  - Steck AK
AU  - Tonyushkina KN
AU  - Veijola R
AU  - Wentworth JM
AU  - Wherrett DK
AU  - Wood JR
AU  - Ziegler AG
AU  - DiMeglio LA
PY  - 2025
JO  - Diabetologia
DO  - 10.1007/s00125-024-06350-x
UR  - https://doi.org/10.1007/s00125-024-06350-x
ER  -

APA

M, P., P, A., A, A., A, A., T, B., KJ, B., REJ, B., E, B., HM, C., JJ, C., ME, C., T, D., C, D. B., K, D., S, D., O, E., H, E. L., BI, F., MP, G., CJ, G., KJ, G., W, H., MJ, H., E, H., RIG, H., HM, I., LM, J., LE, K., O, K., K, L., RW, L., Å, L., I, L., M, L., DM, M., ML, M., C, M., T, O., SP, P., MJ, R., SS, R., DA, S., R, S., KM, S., EK, S., JS, S., C, S., AK, S., KN, T., R, V., JM, W., DK, W., JR, W., AG, Z., & LA, D. (2025). Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter].. Diabetologia. https://doi.org/10.1007/s00125-024-06350-x

Source records

pubmed · retrieved 2026-09-26T04:02:01.856Z